1. Home
  2. CHMI vs SAVA Comparison

CHMI vs SAVA Comparison

Compare CHMI & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.62

Market Cap

83.3M

Sector

Real Estate

ML Signal

HOLD

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.13

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
SAVA
Founded
2012
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
96.1M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
CHMI
SAVA
Price
$2.62
$2.13
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$3.00
$5.00
AVG Volume (30 Days)
177.5K
772.9K
Earning Date
03-05-2026
03-02-2026
Dividend Yield
15.44%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$40,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$31.73
N/A
P/E Ratio
$138.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$1.15
52 Week High
$3.68
$4.98

Technical Indicators

Market Signals
Indicator
CHMI
SAVA
Relative Strength Index (RSI) 44.23 47.99
Support Level $2.54 $2.04
Resistance Level $2.63 $2.22
Average True Range (ATR) 0.06 0.11
MACD -0.02 0.03
Stochastic Oscillator 12.00 62.86

Price Performance

Historical Comparison
CHMI
SAVA

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: